238 related articles for article (PubMed ID: 26225246)
1. Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK.
Wagner C; Zhao P; Pan Y; Hsu V; Grillo J; Huang SM; Sinha V
CPT Pharmacometrics Syst Pharmacol; 2015 Apr; 4(4):226-30. PubMed ID: 26225246
[TBL] [Abstract][Full Text] [Related]
2. Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report.
Wu F; Mousa Y; Raines K; Bode C; Tsang YC; Cristofoletti R; Zhang H; Heimbach T; Fang L; Kesisoglou F; Mitra A; Polli J; Kim MJ; Fan J; Zolnik BS; Sun D; Zhang Y; Zhao L
CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):585-597. PubMed ID: 36530026
[TBL] [Abstract][Full Text] [Related]
3. Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report.
Al Shoyaib A; Riedmaier AE; Kumar A; Roy P; Parrott NJ; Fang L; Tampal N; Yang Y; Jereb R; Zhao L; Wu F
CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):610-618. PubMed ID: 36597353
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New Drugs.
Wu F; Shah H; Li M; Duan P; Zhao P; Suarez S; Raines K; Zhao Y; Wang M; Lin HP; Duan J; Yu L; Seo P
AAPS J; 2021 Feb; 23(2):31. PubMed ID: 33619657
[TBL] [Abstract][Full Text] [Related]
5. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
[TBL] [Abstract][Full Text] [Related]
6. Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials.
Leong R; Vieira ML; Zhao P; Mulugeta Y; Lee CS; Huang SM; Burckart GJ
Clin Pharmacol Ther; 2012 May; 91(5):926-31. PubMed ID: 22472993
[TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation.
Shepard T; Scott G; Cole S; Nordmark A; Bouzom F
CPT Pharmacometrics Syst Pharmacol; 2015 Apr; 4(4):221-5. PubMed ID: 26225245
[TBL] [Abstract][Full Text] [Related]
8. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
9. Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions.
Zhao P; Rowland M; Huang SM
Clin Pharmacol Ther; 2012 Jul; 92(1):17-20. PubMed ID: 22713733
[TBL] [Abstract][Full Text] [Related]
10. Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical Pharmacology.
Zhang X; Yang Y; Grimstein M; Fan J; Grillo JA; Huang SM; Zhu H; Wang Y
J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S160-S178. PubMed ID: 33205429
[TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.
Shebley M; Sandhu P; Emami Riedmaier A; Jamei M; Narayanan R; Patel A; Peters SA; Reddy VP; Zheng M; de Zwart L; Beneton M; Bouzom F; Chen J; Chen Y; Cleary Y; Collins C; Dickinson GL; Djebli N; Einolf HJ; Gardner I; Huth F; Kazmi F; Khalil F; Lin J; Odinecs A; Patel C; Rong H; Schuck E; Sharma P; Wu SP; Xu Y; Yamazaki S; Yoshida K; Rowland M
Clin Pharmacol Ther; 2018 Jul; 104(1):88-110. PubMed ID: 29315504
[TBL] [Abstract][Full Text] [Related]
12. Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report.
Abend A; Heimbach T; Cohen M; Kesisoglou F; Pepin X; Suarez-Sharp S
AAPS J; 2018 Apr; 20(3):60. PubMed ID: 29633092
[TBL] [Abstract][Full Text] [Related]
13. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
[TBL] [Abstract][Full Text] [Related]
14. Have physiologically-based pharmacokinetic models delivered?
Edginton AN; Joshi G
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):929-34. PubMed ID: 21762039
[TBL] [Abstract][Full Text] [Related]
15. PBPK modeling and simulation in drug research and development.
Zhuang X; Lu C
Acta Pharm Sin B; 2016 Sep; 6(5):430-440. PubMed ID: 27909650
[TBL] [Abstract][Full Text] [Related]
16. Physiologically Based Pharmacokinetics Is Impacting Drug Development and Regulatory Decision Making.
Rowland M; Lesko LJ; Rostami-Hodjegan A
CPT Pharmacometrics Syst Pharmacol; 2015 Jun; 4(6):313-5. PubMed ID: 26225258
[TBL] [Abstract][Full Text] [Related]
17. PBPK model reporting template for chemical risk assessment applications.
Tan YM; Chan M; Chukwudebe A; Domoradzki J; Fisher J; Hack CE; Hinderliter P; Hirasawa K; Leonard J; Lumen A; Paini A; Qian H; Ruiz P; Wambaugh J; Zhang F; Embry M
Regul Toxicol Pharmacol; 2020 Aug; 115():104691. PubMed ID: 32502513
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic (PBPK) modeling in children.
Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
[TBL] [Abstract][Full Text] [Related]
19. Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making.
Tan YM; Worley RR; Leonard JA; Fisher JW
Toxicol Sci; 2018 Apr; 162(2):341-348. PubMed ID: 29385573
[TBL] [Abstract][Full Text] [Related]
20. The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement.
Poggesi I; Snoeys J; Van Peer A
Expert Opin Drug Metab Toxicol; 2014 May; 10(5):631-5. PubMed ID: 24517185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
